T-CELL RESPONSE OF ADVANCED AIDS PATIENTS AFTER HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

被引:1
作者
Ai-xia Wang*
机构
关键词
acquired immune deficiency syndrome; highly active antiretroviral therapy; immune reconstitution;
D O I
暂无
中图分类号
R512.91 [获得性免疫缺陷综合征(AIDS艾滋病)];
学科分类号
100401 ;
摘要
Objective To investigate the response on late stage Chinese AIDS patients after highly active antiretroviral therapy (HAART). Methods From October 2002 to March 2004, 20 cases of late stage Chinese AIDS patients were selected to particip-ate in this opened and randomised study, we purposely chose those with CD4+ T cell counts < 100/mm3. All of them had one or two opportunistic infections and none had been treated with anti-HIV drugs. All patients were tested with CD4+ (naive CD4+ T cell defined by CD45RA+ and CD62L+, memory CD4+ T cell defined by CD45RA-), CD8+ T cell, plasma HIV viral load, and clinical manifestations on before, during, and after HAART (5 different regimes) on 1, 3, 6, 9, and 12 months. Results Before HAART mean CD4+ T cell counts were 32 ± 31(range 2-91)/mm3, and plasma HIV viral load were 5.07 ± 0.85(range 2.04-5.70) log copies/mL. In 1 month’s time patients treated with HAART had mean CD4+ and CD8+ T cell counts increasing rapidly. After 1 month the increasing speed turned to slow down, but HIV viral load decreased predominantly within the first 3 months. The major part of increasing CD4+ T cells were memory CD4+ T cells, as for naive CD4+ T cells increasing low and slow. Clinical symptoms and signs improved, and opportunistic infections reduced. The quality of life will be far much better than before. Each patient was followed for 12 months, and had finished 12 months’ HAART. Conclusion This is the first report in China that late stage Chinese AIDS patients after HAART could have their immune reconstitution. The regular pattern is similar to what had been reported in Western countries and also in China. So it is worth to treat late stage Chinese AIDS patients with HAART.
引用
收藏
页码:223 / 225
页数:3
相关论文
共 50 条
  • [31] Impaired CD4 T-Cell Count Response to Combined Antiretroviral Therapy in Antiretroviral-Naive HIV-Infected Patients Presenting With Tuberculosis as AIDS-Defining Condition
    Cingolani, Antonella
    Lepri, Alessandro Cozzi
    Castagna, Antonella
    Goletti, Delia
    De Luca, Andrea
    Scarpellini, Paolo
    Fanti, Iuri
    Antinori, Andrea
    Monforte, Antonella d'Arminio
    Girardi, Enrico
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (06) : 853 - 861
  • [32] Use of highly active antiretroviral therapy in patients with renal insufficiency
    Duggan, JM
    Sahloff, EG
    Moudgal, VV
    PHARMACOTHERAPY, 2005, 25 (05): : 698 - 708
  • [33] A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa
    Mosam, Anisa
    Shaik, Fahmida
    Uldrick, Thomas S.
    Esterhuizen, Tonya
    Friedland, Gerald H.
    Scadden, David T.
    Aboobaker, Jamila
    Coovadia, Hoosen M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (02) : 150 - 157
  • [34] Occurrence of Gastrointestinal Opportunistic Disorders in AIDS Despite the Use of Highly Active Antiretroviral Therapy
    Klaus E. Mönkemüller
    Audrey J. Lazenby
    David H. Lee
    Robert Loudon
    C. Mel Wilcox
    Digestive Diseases and Sciences, 2005, 50 : 230 - 234
  • [35] Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy
    Mönkemüller, KE
    Lazenby, AJ
    Lee, DH
    Loudon, R
    Wilcox, CM
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (02) : 230 - 234
  • [36] AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy
    Bower, M
    Palmieri, C
    Dhillon, T
    CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (01) : 14 - 19
  • [37] Poor quality of sleep associated with low adherence to highly active antiretroviral therapy in Peruvian patients with HIV/AIDS
    Renzo Tello-Velasquez, Jorge
    Eduardo Diaz-Llanes, Bruno
    Mezones-Holguin, Edward
    Rodriguez-Morales, Alfonso J.
    Huamani, Charles
    Hernandez, Adrian V.
    Arevalo-Abanto, Jorge
    CADERNOS DE SAUDE PUBLICA, 2015, 31 (05): : 989 - 1002
  • [38] AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems
    Manfredi, R
    Calza, L
    Chiodo, F
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (04) : 449 - 452
  • [39] Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy
    Gutiérrez, F
    Moltó, J
    Escolano, C
    Mora, A
    Pasquau, F
    Gregori, J
    Nogueira, E
    MEDICINA CLINICA, 2000, 115 (11): : 401 - 404
  • [40] Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients
    Al-Harthi, L
    Voris, J
    Patterson, BK
    Becker, S
    Eron, J
    Smith, KY
    D'Amico, R
    Mildvan, D
    Snidow, J
    Pobiner, B
    Yau, L
    Landay, A
    HIV MEDICINE, 2004, 5 (01) : 55 - 65